Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects

Stroke

Volumn 25, Issue 6, 1994, Pages 1157-1164

  Kuusisto, Johanna ^a   Mykkänen, Leena ^a   Pyörälä, Kalevi ^a   Laakso, Markku ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cerebrovascular disorders; Diabetes; Glucose; Hemoglobin; Insulin

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN;

AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; DIABETES CONTROL; FEMALE; GLUCOSE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; STROKE;

AGED; ALCOHOL DRINKING; ATRIAL FIBRILLATION; BLOOD GLUCOSE; BODY MASS INDEX; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; FINLAND; FOLLOW-UP STUDIES; FORECASTING; HEMOGLOBIN A, GLYCOSYLATED; HUMAN; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; INSULIN; MALE; RISK FACTORS; SEX FACTORS; SMOKING; SUPPORT, NON-U.S. GOV'T;

EID: 0028357761     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.25.6.1157     Document Type: Article

References (38)

1. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev. 1987;3:463-524.
2. Stokes J, Kannel WB, Wolf PA, Cupple LA, D'Agostino RB. The relative importance of selected risk factors for manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation. 1987;65(suppl V):V65-V73.
3. Barrett-Connor E, Khaw K-T. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol. 1988;128:116-123.
4. Yudkin JS. Factors influencing threshold and choice of treatment for hypertension in NIDDM: cardiovascular factors. Diabetes Care. 1991;14(suppl 4):27-32.
5. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22: 312-318.
6. Folsom AR, Prineas RJ, Kaye SA, Munger RG. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke. 1990;21:701-706.
7. Bierman EL. Atherogenesis in diabetes. Arterioscler Thromb. 1992; 12:647-656.
8. Chukwuma C, Tuomilehto J. Diabetes and the risk of stroke. J Diabet Complications. 1993;7:250-262.
9. Fu C, Chang C, Tseng C, Chen M, Kao C, Wu T, Wu H, Chuang L, Chen C, Tai T. Development of macrovascular disease in NIDDM patients in northern Taiwan. Diabetes Care. 1993;16: 137-143.
10. Pyöralä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1972;2:131-141.
11. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin level to the incidence of myocardial infarction and coronary heart disease mortality in middle-aged population. Diabetologia. 1980;19:205-210.
12. Welin L, Eriksson H, Jarsson B, Ohlson LO, Svärdsudd K, Tibblin G. Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia. 1992;35:766-770.
13. Mykkänen L, Laakso M, Uusitupa M, Pyörälà K. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care. 1990;13:1099-1105.
14. Mykkänen L, Laakso M, Penttilä I, Pyörälä K. Asymptomatic hyperglycemia and cardiovascular risk factors in the elderly. Atherosclerosis. 1991;88:153-161.
15. Rose GA, Blackburn H, Gillman RF, Prineas RJ. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization; 1982.
16. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, Mass: John Wright; 1982.
17. World Health Organization. Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and Protocol (MONICA Project). Geneva, Switzerland: World Health Organization; 1983. Publication WHO/MNC/82.1, revision 1.
18. Weinfeld FD, ed. The national survey of stroke. Stroke. 1981; 12(suppl I):I32-I37.
19. World Health Organization. WHO Study Group on Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1985. Technical Report Series No. 727.
20. Hales CN, Randle PJ. Immunoassay of insulin with insulin antibody precipitate. Biochem J. 1963;88:137-146.
21. Faber OK, Binder C. C-peptide response to glucagon: a test for the residual B-cell function in diabetes mellitus. Diabetes. 1977;26: 605-610.
22. Kumar MS, Schumacher P, Deadhan SD. Measurement of serum C-peptide immunoreactivity by radioimmunoassay in insulin- dependent diabetes. Am J Clin Pathol. 1980;74:78-82.
23. 1c by a new liquid-chromatographic assay: methodology, clinical utility and relation to glucose tolerance evaluated. Clin Chem. 1986;32:1867-1872.
24. Penttilä IM, Voutilainen E, Laitinen P, Juutilainen P. Comparison of different analytic and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. Scand J Clin Lab Invest. 1981;41:353-360.
25. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080.
26. Wahlefeld AW. Triglycerides determination after enzymatic hydrolysis. In: Bergmeyer HV, ed. Methods of Enzymatic Analysis. 2nd ed. New York, NY: Verlag Chemie Weinheim and Academic; 1974:1831-1835.
27. International Classification of Diseases, 9th Rev, Vol I: Clinical Modification. Ann Arbor, Mich: Edwards Bros, Inc; 1981.
28. National Diabetes Group, National Institute of Arthritis, Diabetes and Kidney Disease. National Institutes of Health Data Sheet on Prevalence and Incidence of Diabetes in the United States, 1982. Bethesda, Md: National Institutes of Health; 1982.
29. Jovanovic L, Peterson CM. The clinical utility of glycosylated hemoglobin. Am J Med. 1981;70:331-338.
30. Bunn FH. Evaluation of glycosylated hemoglobin in diabetic patient. Diabetes. 1981;30:613-617.
31. Landerson JH, Chan KM, Kilzen P. Glycated hemoglobin and diabetes: a case and overview of the subject. Clin Chem. 1985;31: 1060-1067.
32. Health and Policy Committee, American College of Physicians. Glycosylated hemoglobin in the management and diagnosis of diabetes mellitus. Ann Intern Med. 1984;101:710-713.
33. Lyons TJ. Lipoprotein glycation and its metabolic consequences. Diabetes. 1992;41(suppl 2):67-73.
34. Colwell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes. 1993;42:8-11.
35. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atherosclerosis: a multifactorial disease. Circulation. 1993;87(suppl II): II3-II16.
36. Makita Z, Radoff S, Rayfìeld EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med. 1991;325:826-842.
37. Lyons TJ, Banlie KE, Dyer DG, Dunn JA, Baynes JW. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest. 1991;87: 1910-1915.
38. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyöràlá K, Salonen JT, Karhapäà P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.